Hypotensive Drugs (For Diuretics See 40:28)
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
IRBESARTAN & HYDROCHLOROTHIAZIDE: products 1 to 20 of 36.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Irbesartan/HCTZ 150mg & 12.5mg TabDIN 02387646 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Apo-Irbesartan/HCTZ 300mg & 12.5mg TabDIN 02387654 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Apo-Irbesartan/HCTZ 300mg & 25mg TabDIN 02387662 | General benefit | $0.2184per source unit | Requirements & sourcesBuild cost plan |
| Auro-Irbesartan HCT 150mg & 12.5mg TabDIN 02447878 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Auro-Irbesartan HCT 300mg & 12.5mg TabDIN 02447886 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Auro-Irbesartan HCT 300mg & 25mg TabDIN 02447894 | General benefit | $0.2184per source unit | Requirements & sourcesBuild cost plan |
| Avalide 150mg & 12.5mg TabDIN 02241818 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Avalide 300mg & 12.5mg TabDIN 02241819 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Avalide 300mg & 25mg TabDIN 02280213 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Co Irbesartan/HCT 150mg & 12.5mg TabDIN 02357399 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Co Irbesartan/HCT 300mg & 12.5mg TabDIN 02357402 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Co Irbesartan/HCT 300mg & 25mg TabDIN 02357410 | General benefit | $0.2184per source unit | Requirements & sourcesBuild cost plan |
| Irbesartan HCT 150mg & 12.5mg TabDIN 02385317 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Irbesartan HCT 300mg & 12.5mg TabDIN 02385325 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Irbesartan HCT 300mg & 25mg TabDIN 02385333 | General benefit | $0.2184per source unit | Requirements & sourcesBuild cost plan |
| Irbesartan/HCTZ 150mg & 12.5mg TabDIN 02372886 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Irbesartan/HCTZ 300mg & 12.5mg TabDIN 02372894 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Irbesartan/HCTZ 300mg & 25mg TabDIN 02372908 | General benefit | $0.2184per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Irbesartan and Hydrochlorothiazide 150mg & 12.5mg TabDIN 02418223 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Irbesartan and Hydrochlorothiazide 300mg & 12.5mg TabDIN 02418231 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.